Diagnosing Inflammatory Bowel Disease
Part of Digestive system clinical trials.
This trial looks at how to diagnose Inflammatory Bowel Disease (IBD) in people who have just been diagnosed. It may help find better ways to detect and manage the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been newly diagnosed with Inflammatory Bowel Disease through a tissue sample (biopsy).
- You cannot have serious bowel problems like blockage, a hole, polyps, or bowel cancer.
- You should not be taking NSAIDs (like ibuprofen or aspirin) or drugs that suppress the immune system.
- You must not have other autoimmune diseases (like lupus or rheumatoid arthritis).
- You cannot have a chronic infection such as tuberculosis or other long-term infections.
- You must not be allergic to any medications or substances used in the study.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses simple tests to find out if your long-term stomach issues are caused by a disease like inflammatory bowel disease (IBD) or are just a functional problem. It aims to help doctors know the right treatment for you.
This trial tests a new treatment called CMTS0929 for people with inflammatory bowel disease (IBD), a condition that causes inflammation in the digestive tract. It aims to see if the treatment works and is safe.
This trial looks at two simple blood tests (CRP/albumin ratio and neutrophil-lymphocyte ratio) to see if they can predict disease activity in people with inflammatory bowel disease (IBD). It may help find a faster, less invasive way to monitor your condition.
This study watches people who might be more likely to get Inflammatory Bowel Disease (IBD). It looks at close family members of IBD patients, people with autoimmune diseases, and those with certain digestive issues who also have a specific blood marker (ASCA). The goal is to find early signs and possibly prevent the disease.
This trial studies treatment approaches for inflammatory bowel disease (IBD) in people who are newly diagnosed. It may help researchers find better care by learning how well the study treatment works early in the disease.
This trial tests whether an anti-inflammatory diet can help people with inflammatory bowel disease (IBD). Researchers want to see if this diet reduces inflammation and improves symptoms.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.